Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 3, 2008, Pages 997-1002

  Scheel, Troels K H ^a   Gottwein, Judith M ^a   Jensen, Tanja B ^a   Prentoe, Jannick C ^a   Hoegh, Anne M ^a   Alter, Harvey J ^c   Eugen Olsen, Jesper ^a   Bukh, Jens ^a,b,d  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Egypt; Hepatitis C virus strain ED43; In vitro infection; Intergenotypic recombinant; Vaccine

Indexed keywords

CORE PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; NONSTRUCTURAL PROTEIN 2; PROTEIN 7; RNA; UNCLASSIFIED DRUG; CD81 ANTIGEN; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN;

ANTIBODY TITER; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPROPHYLAXIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA TRANSCRIPTION; STRUCTURAL GENE; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; BLOOD; CELL SURVIVAL; CLASSIFICATION; GENETICS; KINETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; TITRIMETRY; TUMOR CELL LINE; VIROLOGY;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 4;

ANTIGENS, CD; CELL LINE, TUMOR; CELL SURVIVAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; RECOMBINANT PROTEINS; TITRIMETRY; VIRAL CORE PROTEINS;

EID: 38949168945     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711044105     Document Type: Article

References (28)

1. Simmonds P, et al. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
2. Abdo AA, Lee SS (2004) Management of hepatitis C virus genotype 4. J Gastroenterol Hepatol 19:1233-1239.
3. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.
4. Frank C, et al. (2000) The Role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
5. Mohamed MK, et al. (2005) Intrafamilial transmission of hepatitis C in Egypt. Hepatology 42:683-687.
6. Wakita T, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791-796.
7. Zhong J, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102:9294-9299.
8. Lindenbach BD, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309:623-626.
9. Pietschmann T, et al. (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci USA 103:7408-7413.
10. Yi M, Ma Y, Yates J, Lemon SM (2007) Compensatory mutations in E1, P7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81:629-638.
11. Gottwein JM, et al. (2007) Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 133:1614-1626.
12. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol 78:1341-1347.
13. Kalinina O, Norder H, Mukomolov S, Magnius LO (2002) A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 76:4034-4043.
14. Zhong J, et al. (2006) Persistent hepatitis C virus infection in vitro: Coevolution of virus and host. J Virol 80:11082-11093.
15. Meunier JC, et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci USA 102:4560-4565.
16. Yanagi M, Purcell RH, Emerson SU, Bukh J (1997) Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 94:8738-8743.
17. Lavillette D, et al. (2005) Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41:265-274.
18. McKeating JA, et al. (2004) Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol 78:8496-8505.
19. Noppornpanth S, et al. (2006) Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 80:7569-7577.
20. Murayama A, et al. (2007) The NS3 Helicase and NS5B-to-3′X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J Virol 81:8030-8040.
21. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM (2007) Hepatitis C virus P7 and NS2 proteins are essential for production of infectious virus. J Virol 81:8374-8383.
22. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 103:2310-2315.
23. Scarselli E, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21:5017-5025.
24. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446:801-805.
25. von Hahn T, et al. (2007) Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 132:667-678.
26. Logvinoff C, et al. (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 101:10149-10154.
27. Lanford RE, et al. (2004) Cross-genotype immunity to hepatitis C virus. J Virol 78:1575-1581.
28. Prince AM, et al. (1992) Immunity in hepatitis C infection. J Infect Dis 165:438-443.